After an infection with SARS-CoV-2, most people—even those with mild infections—appear
to have some protection against the virus for at least a year, a recent follow-up study of
recovered patients published in Nature suggests. What's more, this and other research
demonstrates that vaccinating these individuals substantially enhances their immune
response and confers strong resistance against variants of concern, including the B. 1.617. 2
(delta) variant. The Backstory Michel Nussenzweig, MD, PhD, and colleagues previously …